Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.

RATIONALE Children who are young, malnourished, and infected with HIV have significant risk of tuberculosis (TB) morbidity and mortality following TB infection. Treatment of TB infection is hindered by poor detection and limited pediatric data. OBJECTIVES Identify improved testing to detect pediatric TB infection. METHODS This was a prospective community-based study assessing use of the tuberculin skin test and IFN-γ release assays among children (n = 1,343; 6 mo to <15 yr) in TB-HIV high-burden settings; associations with child characteristics were measured. MEASUREMENTS AND MAIN RESULTS Contact tracing detects TB in 8% of child contacts within 3 months of exposure. Among children with no documented contact, tuberculin skin test and QuantiFERON-TB Gold In-Tube positivity was greater than T-SPOT.TB. Nearly 8% of children had IFN-γ release assay positive and skin test negative discordance. In a model accounting for confounders, all tests correlate with TB contact, but IFN-γ release assays correlate better than the tuberculin skin test (P = 0.0011). Indeterminate IFN-γ release assay results were not associated with age. Indeterminate QuantiFERON-TB Gold In-Tube results were more frequent in children infected with HIV (4.7%) than uninfected with HIV (1.9%), whereas T-SPOT.TB indeterminates were rare (0.2%) and not affected by HIV status. Conversion and reversion were not associated with HIV status. Among children infected with HIV, tests correlated less with contact as malnutrition worsened. CONCLUSIONS Where resources allow, use of IFN-γ release assays should be considered in children who are young, recently exposed, and infected with HIV because they may offer advantages compared with the tuberculin skin test for identifying TB infection, and improve targeted, cost-effective delivery of preventive therapy. Affordable tests of infection could dramatically impact global TB control.

[1]  I. Kitai,et al.  Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic. , 2015, Journal of the Pediatric Infectious Diseases Society.

[2]  P. Kouw,et al.  Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. , 2014, American journal of respiratory and critical care medicine.

[3]  T. M. Doherty,et al.  Influence of Age and Nutritional Status on the Performance of the Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube in Young Children Evaluated for Tuberculosis in Southern India , 2014, The Pediatric infectious disease journal.

[4]  S. Hammer,et al.  Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure , 2014, PloS one.

[5]  P. Dodd,et al.  Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. , 2014, The Lancet. Global health.

[6]  E. Hershfield,et al.  Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection , 2013, Pediatric Clinical Practice Guidelines & Policies.

[7]  A. Smith,et al.  Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis , 2014, BMC Infectious Diseases.

[8]  R. Gie,et al.  Detecting Tuberculosis Infection in HIV-infected Children: A Study of Diagnostic Accuracy, Confounding and Interaction , 2012, The Pediatric infectious disease journal.

[9]  N. Papadopoulos,et al.  The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. , 2012, The Journal of pediatrics.

[10]  C. Dye,et al.  Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries , 2012, Emerging infectious diseases.

[11]  R. Basu Roy,et al.  Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. , 2012, American journal of respiratory and critical care medicine.

[12]  R. Gie,et al.  Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting , 2012, Thorax.

[13]  P. White,et al.  Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis , 2012, Thorax.

[14]  R. Gie,et al.  Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  C. Sismanidis,et al.  Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. , 2012, The Journal of infectious diseases.

[16]  J. Bellanti,et al.  Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs) , 2012, Allergy and asthma proceedings.

[17]  C. Wiysonge,et al.  The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis , 2011, The Pediatric infectious disease journal.

[18]  A. Benedetti,et al.  Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  K. C. Smith,et al.  Comparing the Tuberculin Skin Test and T-SPOT.TB Blood Test in Children , 2011, Pediatrics.

[20]  I. Adetifa,et al.  Treatment of latent tuberculosis infection in HIV infected persons. , 2010, The Cochrane database of systematic reviews.

[21]  H. Kirchner,et al.  Highly discordant T cell responses in individuals with recent exposure to household tuberculosis , 2008, Thorax.

[22]  F. Cobelens,et al.  Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. , 2007, American journal of respiratory and critical care medicine.

[23]  R. Gie,et al.  A Refined Symptom-Based Approach to Diagnose Pulmonary Tuberculosis in Children , 2006, Pediatrics.

[24]  T. Scriba,et al.  Impaired IFN-γ-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART , 2006, AIDS.

[25]  S. Lawn,et al.  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort , 2005, AIDS.

[26]  J. Deeks,et al.  Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study , 2005, The Lancet.

[27]  R. Gie,et al.  A proposed radiological classification of childhood intra-thoracic tuberculosis , 2004, Pediatric Radiology.

[28]  R. Gie,et al.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  J. Deeks,et al.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.

[30]  C. Gatsonis,et al.  Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative , 2003, Clinical chemistry and laboratory medicine.

[31]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[32]  C. Hung,et al.  Restoration of Cellular Immunity Against Tuberculosis in Patients Coinfected With HIV‐1 and Tuberculosis With Effective Antiretroviral Therapy: Assessment by Determination of CD69 Expression on T Cells After Tuberculin Stimulation , 2000, Journal of acquired immune deficiency syndromes.

[33]  P. Andersen,et al.  Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.

[34]  D. Cook,et al.  Isoniazid for preventing tuberculosis in non-HIV infected persons. , 1999, The Cochrane database of systematic reviews.

[35]  B. Everitt,et al.  Analysis of longitudinal data , 1998, British Journal of Psychiatry.

[36]  P. Albert,et al.  Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.

[37]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[38]  K. H. Hsu,et al.  Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. , 1974, JAMA.

[39]  R. Lodha,et al.  Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis , 2014, European Journal of Clinical Nutrition.

[40]  Sandy F. Price,et al.  Trends in tuberculosis - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[41]  Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle- income countries , 2011 .

[42]  K. Castro,et al.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[43]  Robert H. Pratt,et al.  Trends in tuberculosis--United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[44]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[45]  J. Volmink,et al.  Treatment of latent tuberculosis infection in HIV infected persons. , 2004, The Cochrane database of systematic reviews.